OTC: VASO - Vaso Corporation

Yield per half year: -33.05%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Vaso Corporation


About Vaso Corporation

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services.

more details
The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

IPO date 1988-10-24
ISIN US92233F1021
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://vasocorporation.com
Цена ао 0.13
Change price per day: +0.3155% (0.1268)
Change price per week: -9.14% (0.14)
Change price per month: -9.14% (0.14)
Change price per 3 month: +6% (0.12)
Change price per half year: -33.05% (0.19)
Change price per year: -57.61% (0.3001)
Change price per 3 year: +92.73% (0.066)
Change price per 5 year: +324% (0.03)
Change price per year to date: +6% (0.12)

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0.6667

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 9.71 2
Yield Ebitda, % -927.18 0
Yield EPS, % 11710.34 10
Total: 4.4



Head Job title Payment Year of birth
Dr. Jun Ma Ph.D. President, CEO & Director 921.61k 1963 (62 years)
Mr. Jonathan P. Newton Co-CFO & Treasurer 368.78k 1961 (64 years)
Mr. Michael J. Beecher CPA, CPA Co-CFO & Secretary 149.57k 1945 (80 years)
Mr. Peter C. Castle Chief Operating Officer 442k 1968 (57 years)
Ms. Jane Moen President of VasoHealthcare & Director 729.44k 1980 (45 years)
Mr. Shen Qiuming President of Biox Instruments Co Ltd N/A
Mr. Randy Hill Consultant 105k 1947 (78 years)
Dr. Derek Enlander M.D. Advisor 12k 1946 (79 years)

Address: United States, Plainview. NY, 137 Commercial Street - open in Google maps, open in Yandex maps
Website: https://vasocorporation.com